Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?

被引：4
作者：
Rosso, Kelly J. [1 ]
Weiss, Anna [1 ]
Thompson, Alastair M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, FCT7-6092,Unit 1434,1400 Pressler St, Houston, TX 77030 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2018年 / 27卷 / 01期
关键词：
Ductal carcinoma in situ (DCIS); Active surveillance; Endocrine therapy; INVASIVE BREAST-CANCER; COMPARING TOTAL MASTECTOMY; RANDOMIZED CLINICAL-TRIAL; LYMPH-NODE BIOPSY; QUALITY-OF-LIFE; RECURRENCE RISK; NEEDLE-BIOPSY; CONSERVING SURGERY; PAIN OUTCOMES; FOLLOW-UP;
D O I：
10.1016/j.soc.2017.08.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The management of ductal carcinoma in situ (DCIS) has traditionally followed the evidence base for invasive breast cancer using surgery, radiation therapy, and drug therapy to remove the DCIS from the breast and reduce the risk of recurrence for both DCIS and invasive breast cancer. Because of concerns regarding the overtreatment of DCIS, randomized controlled trials have been established to test the outcomes (invasive breast cancer outcomes and patient-reported outcome measures) of active surveillance compared with guideline-concordant care for low-risk (for progression) DCIS. These strategies are undergoing rigorous evaluation to evaluate alternatives to the current management of DCIS.
引用
收藏
页码：69 / +
页数：13
相关论文
共 38 条
  • [31] Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
    Pilewskie, Melissa
    Stempel, Michelle
    Rosenfeld, Hope
    Eaton, Anne
    Van Zee, Kimberly J.
    Morrow, Monica
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3487 - 3493
  • [32] Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
    Pilewskie, Melissa
    Karsten, Maria
    Radosa, Julia
    Eaton, Anne
    King, Tari A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (07) : 2229 - 2234
  • [33] A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
    Rakovitch, Eileen
    Nofech-Mozes, Sharon
    Hanna, Wedad
    Baehner, Frederick L.
    Saskin, Refik
    Butler, Steven M.
    Tuck, Alan
    Sengupta, Sandip
    Elavathil, Leela
    Jani, Prashant A.
    Bonin, Michel
    Chang, Martin C.
    Robertson, Susan J.
    Slodkowska, Elzbieta
    Fong, Cindy
    Anderson, Joseph M.
    Jamshidian, Farid
    Miller, Dave P.
    Cherbavaz, Diana B.
    Shak, Steven
    Paszat, Lawrence
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (02) : 389 - 398
  • [34] Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France
    Romestaing, P
    Lehingue, Y
    Carrie, C
    Coquard, R
    Montbarbon, X
    Ardiet, JM
    Mamelle, N
    Gerard, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 963 - 968
  • [35] A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
    Solin, Lawrence J.
    Gray, Robert
    Baehner, Frederick L.
    Butler, Steven M.
    Hughes, Lorie L.
    Yoshizawa, Carl
    Cherbavaz, Diana B.
    Shak, Steven
    Page, David L.
    Sledge, George W., Jr.
    Davidson, Nancy E.
    Ingle, James N.
    Perez, Edith A.
    Wood, William C.
    Sparano, Joseph A.
    Badve, Sunil
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (10): : 701 - 710
  • [36] Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ
    Tuttle, Todd M.
    Jarosek, Stephanie
    Habermann, Elizabeth B.
    Arrington, Amanda
    Abraham, Anasooya
    Morris, Todd J.
    Virnig, Beth A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1362 - 1367
  • [37] Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
    van Roozendaal, L. M.
    Goorts, B.
    Klinkert, M.
    Keymeulen, K. B. M. I.
    De Vries, B.
    Strobbe, L. J. A.
    Wauters, C. A. P.
    van Riet, Y. E.
    Degreef, E.
    Rutgers, E. J. T.
    Wesseling, J.
    Smidt, M. L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 517 - 525
  • [38] Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
    Wapnir, Irene L.
    Dignam, James J.
    Fisher, Bernard
    Mamounas, Eleftherios P.
    Anderson, Stewart J.
    Julian, Thomas B.
    Land, Stephanie R.
    Margolese, Richard G.
    Swain, Sandra M.
    Costantino, Joseph P.
    Wolmark, Norman
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (06) : 478 - 488
1234